anti-bcma/cd70 car-t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 13, 2024 (NCT06553898)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CD70 antigenImmunity, passive
CD70 immunity, passive
- BCMAImmunity, passive
BCMA immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06934447 | Phase 1 | Apr 25, 2025 | Chongqing Precision Biotech Co., Ltd, Zhejiang University |
| NCT06553898 | Phase 1 | Aug 13, 2024 | Zhejiang University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang University | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Chongqing Precision Biotech Co., Ltd | For profit | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1